The ambiguity and limit of caffeine in migraine: a literature review

Autores

DOI:

https://doi.org/10.48208/HeadacheMed.2022.Supplement.14

Palavras-chave:

Analgesics, Caffeine, Caffeine withdrawal, Medication overuse, Migraine

Resumo

Introduction

Migraine is a chronic disease that affects about 15% of world's population. It is the most disabling disease among men and women under 50 years. Studies indicate that the caffeine, which is the most consumed stimulating in the world and present on the daily diet, can be related to the migraine in an ambiguous way.

Objective
Considering the epidemiologic and economic point of view, the disease phisiopatology and the accessibility to caffeine, this study aims to understand if there would be a safe minimum dosage of caffeine for patients with migraine.

Methods
The words "migraine" and "caffeine" were searched in July 2022 at PUBMED and BVS with predetermined filters and selection of publication in qualis journals A1 and A2. 13 articles were found for this revision.

Results
Caffeine's effects on the nervous system and its relation with headaches have been target of several studies, mainly for producing symptoms similars to the prodromic phase of migraine e for the existence of the Caffeine Abstinence Syndrome, known as a diagnostic entity by the International Migraine Classification. The sensory hypersensitivity (migraine's characteristic) does not appear at the abstinence syndrome. The lack of information about pre-existing headache at studies shows a gap in the parameter ''caffeine withdrawal as a trigger per se''. It is possible that premonitory symptoms such as yawns, low energy and sleepiness can lead to caffeine intake, bringing forth the wrong idea that it has initiated the migraine.Caffeine, however, induces urinary magnesium loss, reducing its reabsorption. As magnesium affects neuromuscular conduction, nerve transmission and is beneficial in chronic pain conditions and migraines, caffeine, by decreasing magnesium level, can induce headache. Additionally, caffeine contains thiaminases, enzymes that degrade thiamine, which may have protective potential in migraine.  (To see the complete abstract, please, check out the PDF). 

Downloads

Não há dados estatísticos.

Downloads

Publicado

2022-10-27

Como Citar

1.
Deléo RAV, Barroso AE, Souza PM de, Amaral PC do, Oliveira AS de. The ambiguity and limit of caffeine in migraine: a literature review. Headache Med [Internet]. 27º de outubro de 2022 [citado 21º de novembro de 2024];13(Supplement):14. Disponível em: https://headachemedicine.com.br/index.php/hm/article/view/681

Edição

Seção

Resumo Congresso Cefaleia 2024

Artigos Semelhantes

Você também pode iniciar uma pesquisa avançada por similaridade para este artigo.

Artigos mais lidos pelo mesmo(s) autor(es)